Abstract:Background: One of the major underlying causes of mortality in colorectal cancer (CRC) patients is intrinsic resistance to chemotherapy.Emerging evidence suggests that chemoresistance in cancers is linked to a subset of cancer cells termed "cancer stem cells" (CSCs), and splice variants of CD44, in particular v6, are associated with a more aggressive subset of CSCs in CRC.Although microRNAs (miRNAs) are known for their central role in selfrenewal, the molecular mechanisms by which miRNAs regulate an aggressive CSC population remains unexplored.Aims: We aimed to characterize CD44v6-positive CSCs, their role in mediating chemoresistance, and their clinical significance in CRC.Furthermore, we interrogated the miRNA network associated with CD44v6 phenotype in CSCs.Methods: The oncogenic and chemoresistant roles of CD44v6 were assessed by siRNA-mediated knockdown in CRC cell lines and spheroid-derived CSCs (SDCSCs).CD44v6 + /CD44v6 - cells were isolated from SDCSCs and their cellular functions were determined in vitro and in vivo.The clinical significance of CD44v6 was also assessed in two independent clinical patient cohorts.MiRNA-Seq was used to profile CD44v6 + /CD44v6 - SDCSC populations to establish the miRNAnetwork and identify potential miRNA-based therapeutic targets.Results: Over-expression of CD44v6 was confirmed in both chemoresistant CRC cell lines and SDCSCs.Inhibition of CD44v6 resulted in suppressed self-renewal capacity and enhanced sensitivity to chemotherapeutic drugs.Within the SDCSC population, CD44v6 + CSCs showed significantly higher spheroid and colony-forming ability and higher resistance to chemotherapeutic drugs compared to CD44v6 - CSCs.In vivo limiting dilution transplantation assays revealed that CD44v6 +CSCs have remarkably higher tumor initiation ability.Clinically, CD44v6 expression was upregulated in a stage-dependent manner in primary CRCs, and high CD44v6 expression resulted in poorer disease-free and overall survival.MiRNA profiling identified a unique pattern of CD44v6+ SDCSCs indicative of high self-renewal capacity.We discovered that a panel of self-renewal-suppressive miRNAs was downregulated (including miR-34a and miR-101), along with concurrent upregulation of key oncogenic miRNAs (including miR-22 and miR-27) in CD44v6 + CSCs.Conclusion: Collectively, we provide the first evidence that CD44v6 + CSCs are critical mediators of enhanced chemoresistance and tumorigenicity in CRC cells.These findings were further corroborated through associations between high CD44v6 expression and poor prognosis in CRC patients.From a mechanistic viewpoint, we identified a network of dysregulated miRNAs that mediated chemoresistance in CSCs, thus providing a compelling rationale for therapeutic targeting of miRNAs as a potential strategy for overcoming chemoresistance and improved therapeutic response in patients with CRC.

CD44 exerts a functional role during EMT induction in cisplatin-resistant head and neck cancer cells

ZEB1 Promotes Oxaliplatin Resistance Through the Induction of Epithelial - Mesenchymal Transition in Colon Cancer Cells

[CD44 Regulates Epithelial-Mesenchymal Transition and Metastasis in Nasopharyngeal Cancer Cells].

CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells

Expression of CD147 in Advanced Non-Small Cell Lung Cancer Correlated with Cisplatin-Based Chemotherapy Resistance.

471 A Microrna Network Mediates Chemoresistance in Colorectal Cancer Stem Cells

Upregulation of ZNRD1 Enhances Cisplatin Resistance in Human Esophageal Cancer Cells by Regulation of ERCC1 and Bcl-2

Overexpression Of Cd147 Contributes To The Chemoresistance Of Head And Neck Squamous Cell Carcinoma Cells

Perk-Mediated IL8 Secretion Can Enhance the Migration, Invasion, and Cisplatin Resistance of CD10-positive Oral Cancer Cells

Molecular mechanism underlying epithelial‐mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma

The biology and role of CD44 in cancer progression: therapeutic implications

Eradication of CD44-variant positive population in head and neck tumors through controlled intracellular navigation of cisplatin-loaded nanomedicines

CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression

CD44 Potentiates Hepatocellular Carcinoma Migration and Extrahepatic Metastases Via the AKT/ERK Signaling CXCR4 Axis.

Abstract 2566: Mesenchymal to Epithelial Transition Associates with Drug Resistance in Tongue Squamous Cell Carcinoma Cell Line

Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5

CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1

Knockdown of CD44 inhibits the invasion and metastasis of hepatocellular carcinoma both in vitro and in vivo by reversing epithelial-mesenchymal transition

Cisplatin-induced activation of TGF-β signaling contributes to drug resistance

&Lt;p>zfas1 Promotes Cisplatin Resistance Via Suppressing Mir-421 Expression in Oral Squamous Cell Carcinoma</p>

CD44v6-competent Tumor Exosomes Promote Motility, Invasion and Cancer-Initiating Cell Marker Expression in Pancreatic and Colorectal Cancer Cells.